References
- Occupational Lung Disease Group of Labor Hygiene and Occupational Diseases Branch of Chinese Preventive Medicine Association. Consensus of Chinese experts on pneumoconiosis treatment. J Environ Occup Med. 2018;35(8):677–689. doi:10.13213/j.cnki.jeom.2018.18437
- Chinese Society of Tuberculosis, Chinese Medical Association. Guidelines for diagnosis and treatment of non-tuberculous mycobacteria disease (2020 edition). Zhonghua Jie He he Hu Xi Za Zhi. 2020;43(11):918–946. doi:10.3760/cma.j.cn112147-20200508-00570
- Corbett EL, Churchyard GJ, Clayton T, et al. Risk factors for pulmonary mycobacterial disease in South African gold miners. A case-control study. Am J Respir Crit Care Med. 1999;159(1):94–99. doi:10.1164/ajrccm.159.1.9803048
- Nithichanon A, Chetchotisakd P, Matsumura T, et al. Diagnosis of NTM active infection in lymphadenopathy patients with anti-interferon-gamma auto-antibody using inhibitory ELISA vs. indirect ELISA. Sci Rep. 2020;10(1):8968. doi:10.1038/s41598-020-65933-x
- Phelippeau M, Delord M, Drancourt M, Brouqui P. Respiratory tract isolation of Mycobacterium europaeum following influenza infection in an immunocompromised patient: a case report. J Med Case Rep. 2014;8(1):463. doi:10.1186/1752-1947-8-463
- Pourahmad F, Shojaei H, Heidarieh P, Khosravi A, Hashemi A. Report of two cases of Mycobacterium europaeum from Iran. Jpn J Infect Dis. 2012;65(6):539–541. doi:10.7883/yoken.65.539
- Fujiwara K, Furuuchi K, Aono A, et al. Mycobacterium europaeum lung disease in an immunocompetent patient without underlying lung disease. J Infect Chemother. 2021;27(1):107–109. doi:10.1016/j.jiac.2020.09.012
- Cassidy PM, Hedberg K, Saulson A, McNelly E, Winthrop KL. Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin Infect Dis. 2009;49(12):e124–9. doi:10.1086/648443
- Cadena J, Rathinavelu S, Lopez-Alvarenga JC, Restrepo BI. The re-emerging association between tuberculosis and diabetes: lessons from past centuries. Tuberculosis. 2019;1166S:S89–S97. doi:10.1016/j.tube.2019.04.015
- Daley CL, Iaccarino JM, Lange C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Eur Respir J. 2020;56(1):2000535. doi:10.1183/13993003.00535-2020
- Haworth CS, Banks J, Capstick T, et al. British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). Thorax. 2017;72(Suppl 2):ii1–ii64. doi:10.1136/thoraxjnl-2017-210927
- Kwon YS, Koh WJ. Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease. J Korean Med Sci. 2016;31(5):649–659. doi:10.3346/jkms.2016.31.5.649
- Furuuchi K, Morimoto K, Yoshiyama T, et al. Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan. Respir Med. 2019;152:74–80. doi:10.1016/j.rmed.2019.05.001
- Smith GS, Ghio AJ, Stout JE, et al. Epidemiology of nontuberculous mycobacteria isolations among central North Carolina residents, 2006-2010. J Infect. 2016;72(6):678–686. doi:10.1016/j.jinf.2016.03.008
- Winthrop KL, Marras TK, Adjemian J, Zhang H, Wang P, Zhang Q. Incidence and Prevalence of Nontuberculous Mycobacterial Lung Disease in a Large U.S. Managed Care Health Plan, 2008-2015. Ann Am Thorac Soc. 2020;17(2):178–185. doi:10.1513/AnnalsATS.201804-236OC
- Santin M, Barrabeig I, Malchair P, et al. Pulmonary Infections with Nontuberculous Mycobacteria, Catalonia, Spain, 1994-2014. Emerg Infect Dis. 2018;24(6):1091–1094. doi:10.3201/eid2406.172095
- Huang JJ, Li YX, Zhao Y, et al. Prevalence of nontuberculous mycobacteria in a tertiary hospital in Beijing, China, January 2013 to December 2018. BMC Microbiol. 2020;20(1):158. doi:10.1186/s12866-020-01840-5